| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.09M | $ -915.00K | $ -939.00K | $ -340.00K | $ -173.00K |
| Operating Income | $ -31.46M | $ -42.61M | $ -68.72M | $ -62.66M | $ -10.71M |
| EBITDA | $ -31.46M | $ -39.24M | $ -62.05M | $ -38.97M | $ -15.83M |
| Net Income | $ -30.07M | $ -40.16M | $ -65.37M | $ -39.31M | $ -16.62M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.99M | $ 12.78M | $ 52.46M | $ 111.46M | $ 61.79M |
| Total Assets | $ 8.01M | $ 18.22M | $ 59.29M | $ 117.68M | $ 63.19M |
| Total Debt | $ 0.00 | $ 2.50M | $ 3.44M | $ 4.17M | $ 0.00 |
| Net Debt | $ -4.99M | $ -10.28M | $ -8.23M | $ -107.28M | $ -61.79M |
| Total Liabilities | $ 5.28M | $ 7.00M | $ 11.62M | $ 17.36M | $ 5.50M |
| Stockholders' Equity | $ 2.72M | $ 11.22M | $ 47.67M | $ 100.32M | $ 25.38M |
| Cash Flow | |||||
| Free Cash Flow | $ -26.13M | $ -40.45M | $ -59.60M | $ -38.66M | $ -2.28M |
| Operating Cash Flow | $ -26.13M | $ -40.45M | $ -59.60M | $ -33.40M | $ -2.28M |
| Investing Cash Flow | $ 212.00K | $ 41.50M | $ -40.58M | $ -5.26M | $ -65.64M |
| Financing Cash Flow | $ 17.99M | $ 114.00K | $ 280.00K | $ 88.45M | $ 64.07M |
Vincerx Pharma Inc (VINC)
OTHER OTC:VINC
